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1. Introduction 
Immobilized general ligands such as analogues of 
NAD ÷ [1] or AMP [2], have proven most valuable in 
biospecific affinity chromatography forthe separa- 
tion and purification of various enzymes [3,4] and 
isozymes [5]. In the present study we have extended 
the use of an AMP-analogue, N6 -(6-aminohexyl)adeno- 
sine 5'-monophosphate, to achieve asituation of 
'permanent' activation of a regulatory enzyme. The 
enzyme chosen was rabbit muscle glycogen phosphory- 
lase b which has an absolute requirement for the 
effector AMP [6-8]. Three different lines of approach 
were followed to this end: a) the enzyme was strongly 
adsorbed to Sepharose-bound AMP-analogue, b) the 
enzyme and the AMP-analogue were immobilized con- 
currently to Sepharose or alkylamine glass, and c) the 
enzyme was immobilized to Sepharose or alkylamine 
glass in the presence of AMP, to investigate whether 
immobilization i the presence of effector, would 
keep the enzyme in an active conformation even after 
subsequent removal of AMP by exhaustive washing. 
Both procedures a)and b) resulted in 'permanently' 
activated enzyme preparations. 
2. Experimental 
Glycogen phosphorylase b from rabbit muscle, 
a-D-glucose-1 phosphate,/3-glycerophosphate and 
AMP were purchased from Sigma (St. Louis, Mo., 
USA); AMP-free glycogen (type I) from Boehringer 
(Mannheim, Germany); n-hexylamine and L-cysteine 
hydrochloride from Merck (Darmstadt, Germany) and 
extra pure ethylene glycol as well as 2-mercaptoetha- 
nol from BDH (Poole, England). Sepharose 4B and 
Dextran T40 were obtained from Pharmacia (Uppsala, 
Sweden) and alkylamine glass GAO 3940 from 
Coming (Medfield, Mass., USA). The AMP-analogue, 
N 6-(6-aminohexyl)adenosine-5'-monophosphate, was 
prepared as described elsewhere [2]. 
Phosphorylase b was bound to Sepharose 4B by 
the CNBr method [9] and coupling allowed to 
proceed overnight in a rotating test tube at 4°C in 
4 ml 0.1 M NaHCO3. About 1.2 mg protein and, 
where appropriate, 15 mg AMP or AMP-analogue 
were added to 2 g wet gel (0.1 g dry weight). The 
preparation was thoroughly washed with 0.1 M 
NaHCO3,0.5 M NaC1, 45% ethylene glycol in 0.1 M 
KC1 and 0.05 M glycerophosphate-0.04 M cysteine 
buffer pH 6.8. Phosphorylase b was coupled to 
alkylamine glass (pore diameter 550 A) following 
activation by 2.5% glutaraldehyde [ 10]. In general 
24  mg protein and 20 mg AMP or AMP-analogue 
were used per 0.5 g dry glass in 5 ml 0.1 M glycero- 
phosphate buffer pH 6.8. The preparations were 
washed as above. Coupling yields of protein were 
determined by amino acid analysis [11 ] and the 
amount of AMP-analogue was determined by phos- 
phate analysis [ 12]. 
The AMP-analogue was immobilized on its own 
to Sepharose or to soluble dextran (MW 40 000) 
by the CNBr technique. The dextron preparation 
was purified by ethanolic precipitation and separation 
on a Sephadex G-50 column in 0.25 M LiC1 [13]. 
The concentration f bound AMP-analogue was deter- 
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mined from its absorbance at267 nm (e = 17 300) 
and the amount of dextran with the anthrone 
reagent [14]. 
Enzyme activities were measured in the direction 
of glycogen synthesis [15]. The free enzyme was 
passed through aSephadex G-25 column prior to 
use to remove any AMP present. The immobilized 
preparations were assayed at 28°C in a total volume 
of 4.8 ml with 1% glycogen, 0-4  mM AMP or AMP- 
analogue and 32 mM glucose-I-phosphate, all adjusted 
to pH 6.8, in 19 mM glycerophosphate-15 mM
cysteine buffer pH 6.8. The reaction vessel was 
placed in a shaker in a thermostated bath (Braun- 
Melsungen) and aliquots of 50/al were withdrawn 
through a filter every five or ten minutes analysed 
for free phosphate. 
In the column assays about 0.5 ml Sepharose pre- 
paration was packed in a small column and the sub- 
strate solution (1% glycogen and 32 mM glucose-l- 
phosphate in 50 mM glycerophosphate-15 mM
mercaptoethanol buffer pH 6.8), total volume 2.0 ml, 
was continuously circulated at room temperature 
with a LKB-Beckman peristaltic pump. 
3. Results and discussion 
In the initial phase of this investigation the free 
AMP-analogue was tested to establish whether, and 
to what degree, it would replace AMP as an effector 
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Fig. 1. Activation of soluble glycogen phosphorylase b with 
AMP (o), AMP-analogue (zx) and dextran-bound AMP- 
analogue (o). 
activated about 80% relative to unmodified AMP 
with a K a, taken as the nucleotide concentration 
at half maximum activation, of 5 • 10 -4 M compared 
to aK a of 8.10 -s M for AMP. This activation was 
not unexpected in view of the large number of 
other analogues reported to affect phosphorylase b 
[16,17]. 
In the next step the analogue was immobilized 
through its amino-group to a water-soluble dextran 
to establish whether the amino-group, either on the 
AMP or on the analogue, is required for enzyme 
activation and whether abulky support will decisively 
impede activation. Fig. 1 shows that these prepara- 
tions (about 150/1moles of analogue bound per g 
dry dextran) activated phosphorylase b by about 
30% relative to free AMP indicating steric hindrance 
by the water-soluble support. Such polymer prepara- 
tions may well find practical application when co- 
entrapped with the enzyme in polymer beads. 
In the following stage attempts were made to 
decide whether phosphory!ase could be activated 
by a preparation comprising the AMP-analogue 
immobilized to a particulate support such as 
Sepharose. In the test the bound effector preparation 
(150/lmoles of analogue per g dry Sepharose) was 
packed in a column as described in the experimental 
section and a solution containing enzyme, glucose-I- 
phosphate and the primer glycogen was circulated 
continuously through the bed. Fig. 2 shows that line 
A, which represents he synthesis of polysaccharide 
measured as the release of inorganic phosphate, was 
linear through the first 30 min. The amount of 
product formed per minute and per mg of enzyme 
during this initial phase was about 20% relative to 
that for the same amount of enzyme when activated 
with free AMP, or 25% compared to activation with 
free AMP-analogue. It is most likely that steric 
hindrance imposed by the matrix accounts for the 
lower degree of activation. In a control experiment 
under identical conditions but omitting the enzyme 
no phosphate was liberated. Furthermore, it was 
shown conclusively that no AMP-analogue had 
leaked out into the solution since addition of free 
phosphorylase to an aliquot of this solution did not 
release any free phosphate. 
In a subsequent experiment, the question as to 
whether the enzyme is firmly bound to the immobi- 
lized effector, or is in equilibrium with the mobile 
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Fig. 2. Activity measurements of phosphorylase b in a 2 ml 
recycling system (15 ml/hr) over a column (7 × 0.6 cm) con- 
raining the packed Sepharose preparation. Aliquots of 50 ~1 
were withdrawn and analysed on the contents of inorganic 
phosphate. A: 0.5 ml AMP-analogue-Sepharose with 0.2 mg 
phosphorylase b recycled in substrate solution (1% glycogen 
and 32 mM glucose-l-phosphate in 50 mM glycerophosphate- 
15 mM mercaptoethanol buffer pH 6.8). B: 0.5 ml AMP- 
analogue-Sepharose with adsorbed phosphorylase b (i.e. no 
free enzyme circulating in the solution). Recycling of sub- 
strate solution as above. C: The above Sepharose preparation 
after washing the column with ice-cold 45% ethylene glycol 
in 0.1 M KC1. D: 0.75 ml Sepharose with AMP-analogue 
and phosphorylase b both covalently bound to the matrix. 
This preparation had previously been washed with ethylene 
glycol as above. 
phase, was investigated. The column was washed 
with buffer and then excessively with substrate 
solution (glucose-1-phosphate ndglycogen in buffer), 
which eluted more enzyme. When no more enzyme 
was released from the column the system was re- 
circulated as above and the activity given as line B 
in fig. 2 was measured. This rate is far lower than 
that observed in the first case (line A), where 
probably more enzyme is oriented around the 
effector and the excess of enzyme present in the 
circulating system is likely to displace the equilibrium 
even further towards formation of the enzyme- 
immobilized effector complex (Kdiss for enzyme- 
AMP of about 1 • 10 -4 M has been reported in [7]). 
Controls revealed that no enzyme leaked from the 
column since the same rate was obtained at several 
1 hr intervals, and no free enzyme could be detected 
in the solution. Thus the enzyme remained immo- 
bilized in its active conformation on the column. It 
is not unlikely that this binding of the enzyme 
includes a hydrophobic contribution from the inter- 
action between the lipophilic hexamethylene spacer 
of the ligand and the hydrophobic site known to 
exist in the enzyme [18]. 
In the two other approaches to obtain 'freezing' 
of phosphorylase b in its active state, the enzyme 
was bound to a CNBr-activated Sepharose matrix. 
As is seen from Table 1, the specific activities 
obtained for the various preparations are relatively 
high and lie in the range of 15-30% compared to 
free enzyme. It appears that the presence of effector 
or effector-analogue during coupling protects the 
enzyme in analogy to earlier observations made 
during the entrapment of hexokinase in polyacryl- 
amide beads [19]. The specific activities of Sepharose- 
bound phosphorylase are equivalent to those found 
by other authors [20]. 
Comparable results were obtained when the 
enzyme was bound to glutaraldehyde treated alkyl- 
amine glass, although the specific activities were 
somewhat lower, approximately 15% (2.2 #moles Pi- 
mg- ~ • min- 1 ), with binding yields of about 50%. 
Whether both subunits of the dimeric enzyme 
(MW ~ 200 000) are covalently bound to the matrices 
has not yet been established, but it appears likely in 
view of the size of the protein and extent of activation 
of the matrices. 
When the enzyme was coupled in the presence of 
10 mM AMP no activity was found in the exhaustively 
washed preparation unless AMP was re-added. 
Evidently, the presence of effector did not assist in 
the stabilization of the enzyme in an active conform- 
ation that could be immobilized through the, likely 
occurring, multiple points of attachment. This would 
be in accordance with the reported concept hat the 
effector-induced conformational changes are restricted 
to a small region on the enzyme [8]. 
However, when the enzyme was bound in the 
presence of the AMP-analogue (10 mM), with its free 
amino-group suitable for binding to a matrix, then 
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Table 1 
Binding yield and specific activity of Sepharose-bound glycogen phosphorylase b. 
Phosphorylase b 
preparations 
Specific activity Binding Yield 
-AMP +AMP +AMP-analogue mg protein/g 
(optimal) a (optimal) a dried support 
% Of added 
protein bound 
Soluble native 
phosphorylase b 0 
Sepharose-bound 
phosphorylase b 0 
Phosphorylase b 
bound to Sepharose in
presence of 10 mM AMP 0 
Phosphorylase b and 
AMP-analogue (10 mM) 
concurrently bound to 
Sepharose 1.4 
(~mole Pi ' mg-I rain -~) 
14.6 (100%) b 12.4 (100%) b - - 
2.4 (16%) b 2.3 (19%) b 5.9 48 
3.9 (27%) b 3.8 (31%) b 5.4 43 
4.3 (30%) b 3.8 (31%) b 4.2 c 33 
a Optimal nucleotide concentrations were in the range of 1-4 mM. 
b The values in brackets give the specific activities of the various immobilized preparations inper cent relative to the soluble 
phosphorylase b. 
c The amount of covalently bound AMP-analogue was 70 #moles (30 mg)/g dried support. 
active preparations were obtained even though 
excessive washing was carried out to remove non- 
covalently bound analogue. The time course of  a 
typical preparation during recycling in a column is 
plotted in fig. 2 as line D. Table I shows that 
about 30% (the mean of several determinations) of
the maximum activity, obtainable with a saturating 
concentration of  native AMP, was achieved without 
any 'external' addition of effector. This figure cor- 
responds to 40% of that obtainable with saturating 
concentrations of free AMP-analogue. 
The preparations were washed with 45% ethylene 
glycol in 0.1 M KC1 to remove any analogue bound 
to the enzyme by possible hydrophobic interaction. 
In controls run such conditions were sufficient o 
release the free AMP-analogue from Sepharose-bound 
phosphorylase. Likewise when 0.1 M AMP in 25% 
ethylene glycol was employed as an alternative 
washing procedure the free AMP-analogue was washed 
off, but the analogue when bound together with the 
enzyme to activated Sepharose, was not. 
When the ethylene glycol treatment was applied 
to the biospecifically adsorbed enzyme preparation 
(fig. 2, line B) then all the enzyme was removed 
(fig. 2, line C). This again shows that the enzyme in 
the above preparations was covalently bound to the 
matrix, and not merely physically adsorbed to the 
immobilized effector. 
When a glass matrix was used instead of Sepharose, 
similarly active phosphorylase preparations were 
obtained prior to any addition of soluble effector. 
While this work was in progress a report appeared 
on the preparation of partially active phosphorylase b 
with a nucleotide-analogue covalently bound to the 
protein itself [21 ]. The enzyme precipitated, how- 
ever, on increasing the nucleotide concentration, 
probably due to side reactions of the nucleotide with 
the enzyme. 
To our knowledge the present study is the first 
report on the successful immobilization of an effector- 
dependent enzyme in its active conformation on a 
matrix such that no requirement was shown for the 
addition of effector to induce activity. In the case 
where the enzyme was simply added to the matrix- 
bound AMP-analogue, the high affinity of the enzyme 
for the immobilized effector sufficed to keep the 
enzyme immobilized in its active conformation. 
In the alternative case the enzyme is covalently 
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bound to the matrix and apparently kept oriented 
around the immobilized effector. With these prepara- 
tions the initial activities (without soluble effector 
added) varied and the value given in table 1 is 
the mean of several preparations. The competit ion 
during binding of the nucleotide and enzyme for the 
activated matrix may in part account for these 
variations. The fact that addition of free AMP or 
analogue does increase the degree of activation is 
probably due to the fact that many molecules are not 
oriented optimally towards the immobilized effector. 
It should be worthwhile attempting the stabiliza- 
tion of other enzymes in their active conformation i  
this or other ways, and characterizing them in terms of 
kinetics, reaction sequence and stability. Further- 
more, the fact that the requirement for soluble 
effector molecules can be abolished is of value for 
effector-dependent zymes of potential practical 
interest. 
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